DE60021109D1 - Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel - Google Patents

Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel

Info

Publication number
DE60021109D1
DE60021109D1 DE60021109T DE60021109T DE60021109D1 DE 60021109 D1 DE60021109 D1 DE 60021109D1 DE 60021109 T DE60021109 T DE 60021109T DE 60021109 T DE60021109 T DE 60021109T DE 60021109 D1 DE60021109 D1 DE 60021109D1
Authority
DE
Germany
Prior art keywords
amycomycin
medicament
preparation
stereoisomeric
dsm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60021109T
Other languages
English (en)
Other versions
DE60021109T2 (de
Inventor
Cordula Hopmann
Michael Kurz
Heinrich Decker
Beller Dominique Le
Jozsef Aszodi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of DE60021109D1 publication Critical patent/DE60021109D1/de
Publication of DE60021109T2 publication Critical patent/DE60021109T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
DE60021109T 1999-12-08 2000-11-25 Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel Expired - Lifetime DE60021109T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99124456A EP1106604A1 (de) 1999-12-08 1999-12-08 Amycomycin, Verfahren zu dessen Herstellung und seine Verwendung als Arzneimittel
EP99124456 1999-12-08
PCT/EP2000/011752 WO2001042210A1 (en) 1999-12-08 2000-11-25 Amycomycin, a process for its production and its use as a pharmaceutical

Publications (2)

Publication Number Publication Date
DE60021109D1 true DE60021109D1 (de) 2005-08-04
DE60021109T2 DE60021109T2 (de) 2006-05-04

Family

ID=8239554

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60021109T Expired - Lifetime DE60021109T2 (de) 1999-12-08 2000-11-25 Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel

Country Status (28)

Country Link
US (1) US6642391B2 (de)
EP (2) EP1106604A1 (de)
JP (1) JP4750993B2 (de)
KR (1) KR100728514B1 (de)
CN (1) CN1217929C (de)
AT (1) ATE298744T1 (de)
AU (1) AU781398B2 (de)
BR (1) BR0016223A (de)
CA (1) CA2393518C (de)
CZ (1) CZ294370B6 (de)
DE (1) DE60021109T2 (de)
DK (1) DK1237866T3 (de)
EE (1) EE05219B1 (de)
ES (1) ES2243332T3 (de)
HK (1) HK1048998A1 (de)
HR (1) HRP20020497B1 (de)
HU (1) HU225194B1 (de)
IL (2) IL149904A0 (de)
ME (1) ME00182B (de)
NO (1) NO322565B1 (de)
PL (1) PL201809B1 (de)
PT (1) PT1237866E (de)
RS (1) RS50288B (de)
RU (1) RU2261916C2 (de)
SI (1) SI1237866T1 (de)
SK (1) SK286776B6 (de)
WO (1) WO2001042210A1 (de)
ZA (1) ZA200204420B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
CA2016382A1 (en) * 1989-05-12 1990-11-12 Marvin M. Hoehn A59770 antibiotics
JPH05163289A (ja) * 1991-08-27 1993-06-29 Microbial Chem Res Found 新規な免疫抑制物質、mi710−51f6物質およびその製造法
JPH05286990A (ja) * 1992-04-08 1993-11-02 Meiji Seika Kaisha Ltd 新規マクロライド抗生物質および微生物変換を利用したマクロライド抗生物質の製造法
JP3107455B2 (ja) * 1992-05-08 2000-11-06 財団法人微生物化学研究会 新規抗生物質mi481−42f4−a及びその製造方法
JPH05317068A (ja) * 1992-05-14 1993-12-03 Kaiyo Bio Technol Kenkyusho:Kk 抗生物質マグネシジンの一成分の選択的製造法
JPH0733736A (ja) * 1993-07-26 1995-02-03 Microbial Chem Res Found 新規抗生物質アジセマイシンbおよびその製造方法
JPH09157266A (ja) * 1995-12-04 1997-06-17 Microbial Chem Res Found 新規抗生物質エポキシキノマイシンaおよびbとその製造法
EP0816539A1 (de) 1996-07-05 1998-01-07 Maschinenfabrik Rieter Ag Verfahren und Vorrichtung zur Produktionssteuerung an einer Karde
JPH1045738A (ja) * 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンcおよびdとその製造法ならびに抗リウマチ剤
JPH10114777A (ja) * 1996-10-09 1998-05-06 Microbial Chem Res Found 抗生物質スピロキシマイシンとその製造法

Also Published As

Publication number Publication date
US20010018450A1 (en) 2001-08-30
JP4750993B2 (ja) 2011-08-17
CZ294370B6 (cs) 2004-12-15
AU781398B2 (en) 2005-05-19
KR20020063205A (ko) 2002-08-01
HRP20020497B1 (en) 2006-04-30
SI1237866T1 (en) 2005-10-31
JP2003516389A (ja) 2003-05-13
KR100728514B1 (ko) 2007-06-15
RU2002118116A (ru) 2004-02-27
HU225194B1 (en) 2006-08-28
DK1237866T3 (da) 2005-10-10
IL149904A0 (en) 2002-11-10
SK286776B6 (sk) 2009-05-07
SK7872002A3 (en) 2002-11-06
RU2261916C2 (ru) 2005-10-10
ZA200204420B (en) 2003-09-03
US6642391B2 (en) 2003-11-04
CN1217929C (zh) 2005-09-07
RS50288B (sr) 2009-09-08
EP1237866B1 (de) 2005-06-29
ES2243332T3 (es) 2005-12-01
EP1237866A1 (de) 2002-09-11
DE60021109T2 (de) 2006-05-04
HRP20020497A2 (en) 2004-08-31
EE200200280A (et) 2003-06-16
HUP0203593A2 (hu) 2003-02-28
HK1048998A1 (en) 2003-04-25
ATE298744T1 (de) 2005-07-15
HUP0203593A3 (en) 2003-12-29
CN1377341A (zh) 2002-10-30
MEP28508A (en) 2010-10-10
YU13102A (sh) 2005-06-10
ME00182B (me) 2010-10-10
EP1106604A1 (de) 2001-06-13
NO20022654D0 (no) 2002-06-05
BR0016223A (pt) 2002-09-10
NO20022654L (no) 2002-06-05
CA2393518A1 (en) 2001-06-14
WO2001042210A1 (en) 2001-06-14
CA2393518C (en) 2009-01-20
AU2001901A (en) 2001-06-18
IL149904A (en) 2007-10-31
PT1237866E (pt) 2005-10-31
EE05219B1 (et) 2009-10-15
CZ20021891A3 (cs) 2002-08-14
NO322565B1 (no) 2006-10-23
PL201809B1 (pl) 2009-05-29
PL355627A1 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
AU1025795A (en) Prolineamide derivatives
AU6788296A (en) Use of adamantane derivatives for treating diseases of the inner ear
DE69620443T2 (de) Naphthyl substituierte benzimidazolderivate als antikoagulantien
ATE179706T1 (de) N-heteroaryl-n'-phenylharnstoffderivate, ihre herstellung und verwendung
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
NO324229B1 (no) 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse
ES2132135T3 (es) Procedimiento para la preparacion de compuestos de tiazolidina u oxazolidina farmaceuticamente activos mediante una reductasa de levadura.
FI101227B1 (fi) Menetelmä farmaseuttisesti aktiivisten 4-desoksi-4-epipodofyllotoksiinijohdannaisten valmistamiseksi
ATE100097T1 (de) Benzoxepin-derivate.
DE60021109D1 (de) Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
AU1390692A (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
AU4209693A (en) Novel piperidine derivatives and process for preparation thereof
HU9803043D0 (en) Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-azo-9a-homoerythromycin-a
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,

8364 No opposition during term of opposition